These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16918344)

  • 21. International consensus on clinical use of presynaptic dopaminergic positron emission tomography imaging in parkinsonism.
    Tian M; Zuo C; Cahid Civelek A; Carrio I; Watanabe Y; Kang KW; Murakami K; Prior JO; Zhong Y; Dou X; Yu C; Jin C; Zhou R; Liu F; Li X; Lu J; Zhang H; Wang J;
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):434-442. PubMed ID: 37789188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [18F]desmethoxyfallypride as a novel PET radiotracer for quantitative in vivo dopamine D2/D3 receptor imaging in rat models of neurodegenerative diseases.
    Döbrössy MD; Braun F; Klein S; Garcia J; Langen KJ; Weber WA; Nikkhah G; Meyer PT
    Nucl Med Biol; 2012 Oct; 39(7):1077-80. PubMed ID: 22591915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of [18F]FDOPA, [18F]FMT and [18F]FECNT for imaging dopaminergic neurotransmission in mice.
    Honer M; Hengerer B; Blagoev M; Hintermann S; Waldmeier P; Schubiger PA; Ametamey SM
    Nucl Med Biol; 2006 Jul; 33(5):607-14. PubMed ID: 16843835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utilization of radioligands in schizophrenia research.
    Sedvall G; Farde L; Hall H; Halldin C; Karlsson P; Nordström AL; Nyberg S; Pauli S
    Clin Neurosci; 1995; 3(2):112-21. PubMed ID: 7583617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopaminergic function and intertemporal choice.
    Joutsa J; Voon V; Johansson J; Niemelä S; Bergman J; Kaasinen V
    Transl Psychiatry; 2015 Jan; 5(1):e491. PubMed ID: 25562841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normative data of dopaminergic neurotransmission functions in substantia nigra measured with MRI and PET: Neuromelanin, dopamine synthesis, dopamine transporters, and dopamine D
    Ito H; Kawaguchi H; Kodaka F; Takuwa H; Ikoma Y; Shimada H; Kimura Y; Seki C; Kubo H; Ishii S; Takano H; Suhara T
    Neuroimage; 2017 Sep; 158():12-17. PubMed ID: 28655632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing diagnosis in Parkinson's disease: Radionuclide imaging.
    Arena JE; Stoessl AJ
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S47-51. PubMed ID: 26439947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurodegenerative movement disorders: the contribution of functional imaging.
    Piccini P
    Curr Opin Neurol; 2004 Aug; 17(4):459-66. PubMed ID: 15247543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine synthesis capacity correlates with µ-opioid receptor availability in the human basal ganglia: A triple-tracer PET study.
    Majuri J; Joutsa J; Arponen E; Forsback S; Kaasinen V
    Neuroimage; 2018 Dec; 183():1-6. PubMed ID: 30077742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Receptor mapping in living human beings by means of positron emission tomography].
    Gjedde A
    Ugeskr Laeger; 2001 Sep; 163(38):5199-205. PubMed ID: 11577527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches.
    Kumakura Y; Cumming P
    Neuroscientist; 2009 Dec; 15(6):635-50. PubMed ID: 19793723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Imaging of the Dopaminergic System in Idiopathic Parkinson's Disease.
    de Natale ER; Niccolini F; Wilson H; Politis M
    Int Rev Neurobiol; 2018; 141():131-172. PubMed ID: 30314595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of 6-[(11)C]methyl-m-tyrosine ([(11)C]6MemTyr) for dopamine synthesis imaging in living brain using PET.
    Kanazawa M; Ohba H; Iwazaki A; Kakiuchi T; Tsukada H
    Bioorg Med Chem; 2015 Feb; 23(4):729-34. PubMed ID: 25596169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The discovery of epidepride and its analogs as high-affinity radioligands for imaging extrastriatal dopamine D(2) receptors in human brain.
    de Paulis T
    Curr Pharm Des; 2003; 9(8):673-96. PubMed ID: 12570798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis.
    Tsukada H; Harada N; Nishiyama S; Ohba H; Sato K; Fukumoto D; Kakiuchi T
    Synapse; 2000 Aug; 37(2):95-103. PubMed ID: 10881030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous competition against binding of [(18)F]DMFP and [(18)F]fallypride to dopamine D(2/3) receptors in brain of living mouse.
    Rominger A; Wagner E; Mille E; Böning G; Esmaeilzadeh M; Wängler B; Gildehaus FJ; Nowak S; Bruche A; Tatsch K; Bartenstein P; Cumming P
    Synapse; 2010 Apr; 64(4):313-22. PubMed ID: 19957365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pain-related opioidergic and dopaminergic neurotransmission: Dual meta-Analyses of PET radioligand studies.
    Garcia Guerra S; Spadoni A; Mitchell J; Strigo IA
    Brain Res; 2023 Apr; 1805():148268. PubMed ID: 36754138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders.
    Virdee K; Cumming P; Caprioli D; Jupp B; Rominger A; Aigbirhio FI; Fryer TD; Riss PJ; Dalley JW
    Neurosci Biobehav Rev; 2012 Apr; 36(4):1188-216. PubMed ID: 22342372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of dopamine in positive and negative prediction error utilization during incidental learning - Insights from Positron Emission Tomography, Parkinson's disease and Huntington's disease.
    Mathar D; Wilkinson L; Holl AK; Neumann J; Deserno L; Villringer A; Jahanshahi M; Horstmann A
    Cortex; 2017 May; 90():149-162. PubMed ID: 27751503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.